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ABSTRACT
This research was aimed to study the effect of dietary taurine on the toxicity of oxidized cholesterol in male Wistar rats. The
rats were divided into eight groups and fed different diets with or without supplement of 5% taurine and 3% oxidized cholesterol for
8 weeks. To evaluate effects of taurine at the same time, before diets and after diets in the food, after feeding diet with 3% oxidized
cholesterol and 5% taurine at the same time, taurine could improve the decrease of body weight and the glutathione (GSH) level in the
liver, and the increase of relative ratio of liver or kidney weight to body weight and thiobarbituric acid-reactive substances (TBARS)
level in the liver of rats caused by oxidized cholesterol (P < 0.05). It also could inhibit the activities of aspartate transaminase (AST),
alanine transaminase (ALT) and alkaline phosphatase (ALP) in the plasma of rats caused by oxidized cholesterol (P < 0.05). It was
also found that taurine possessed a good recovering effect and a short-term preventing effect the toxicity of oxidized cholesterol in
rats. Judging from these data, on taurine may play an important role in diminishing the toxic effect of oxidized cholesterol in rats.
Key words: taurine, oxidized cholesterol, toxic effect, rats, liver function

INTRODUCTION
Cholesterol is found in foods of animal sources, for
example, egg yolks, meat and cheese. Pure cholesterol is
essential for cell survival, whereas even small amounts of
oxidized cholesterol produce significant toxicity. Cholesterol is readily oxidized in common foods through exposure to oxygen and high temperature, ultraviolet irradiation and reaction with free radicals during processing
or storage. Oxidized cholesterol exhibits deleterious
biological activities including cytotoxicity, mutagenicity, carcinogenicity, atherogenicity, inhibition of sterol
biosynthesis and modulation of immune function in
many in vitro studies (1-4). Research provides evidence
that some cholesterol oxides are toxic and may facilitate
the development of coronary artery disease and certain
cancers.(1, 5-10). Thus, dietary oxidized cholesterol seems
to be a biologically deleterious agent on lipid metabolism; however, the regulation against oxidized cholesterol-induced untoward actions has not been explored until
now.
Taurine (2-amino ethanesulfonic acid) is the major
free intracellular amino acid present in many tissues
* Author for correspondence. Tel.: +886-5-3622-889;
Fax: +886-5-3622-899;
E-mail address: yhyeh@mail.toko.edu.tw (Y. H. Yeh).

and has various biological and physiological functions,
including cell membrane stabilization(11), antioxidation(12), detoxification(13), osmoregulation(14), neuromodulation(15), and brain and retinal development (16).
Also, taurine plays an important role in lipid metabolism
to produce the bile acid conjugates in the liver; that is,
taurine increases the utilization of bile acid which is the
degrading metabolite of cholesterol and participates in
fat absorption(17). A number of studies concerning the
hypocholesterolemic action of taurine have been conducted using cholesterol-loading animals. Previous studies demonstrated that taurine had a cholesterol lowering
effect in rats and mice, but not in rabbits (18-20). In this
study, the model was used for an evaluation of oxidized
cholesterol on dietary protection of taurine at the same
time, before diets and after diets in the rats was studied.

MATERIALS AND METHODS
I. Reagents
Taurine was purchased from Dokui Chemical
Company (Taiwan), purify of 99.5% to add of 5% in
the feed. The corn oil was supplied from President Co.
(Taiwan).
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II. Preparation of Oxidized Cholesterol
Cholesterol (99.9% purity, Wako Chemical, Osaka,
Japan) was heated at 150°C for 12 h to produce oxidized
cholesterol(21), a peroxide value (POV) of approximately 50.2 meq/kg oil, a content of the thiobarbituric acid
reactive substances (TBARS) of 1.58 mg/kg oil and a
content of the acid value (AV) 1.74 mg/g oil. The value
of POV, AV and TBA in the oil was determined by AOAC
method (22).
III. Animals
Male weanling Wistar rats were purchased from the
National Laboratory Animal Center. They were kept in
an air-conditioned room (23 ± 1°C, 50-60% humidity)
lit for 12 hr/day (7 AM to 7 PM). Experimental protocol
was approved by the Institutional Animal Care and Use
Committee of Toko University. After acclimatizing for 2
wk with a commercial non-purified diet (rodent Laboratory Chow 5001, Purina Co., USA), 48 rats were divided
into eight groups. Six rats in each group were assigned to
receive an 8-wk period of one or two of four formulated
diets (Table 1). The diets were synthesized as described
previously by the American Institute of Nutrition(23) and
included: basal diet (received the control diet), taurine
diet (5% taurine in diet), oxidized cholesterol diet (3%
oxidized cholesterol), and oxidized cholesterol+taurine
diet (3% oxidized cholesterol+5% taurine). The concentration of taurine in fish read 5% (24), so 5% taurine was

added in the experimental diets. The diet regimen used
in each group was as follows. The oxidized cholesterol
on dietary protection of taurine at the same time, before
diets and after diets in the rats was studied. Dietary of
taurine at the same time Group A: rats were fed with
basal diet for 2 months. Group B: rats were fed with
taurine diet for 2 months. Group C: rats were fed with
oxidized cholesterol diet for 2 months. Group D: rats were
fed with taurine+oxidized cholesterol diet for 2 months.
Taurine after diets Group E: rats were fed with oxidized
cholesterol diet for 1 month and then with taurine diet
for 1 month. Taurine before diets Group F: rats were
fed with oxidized cholesterol diet for 1 month and then
with basal diet for 1 month. Group G: rats were fed with
taurine diet for 1 month and then with oxidized cholesterol diet for 1 month. Group H: rats were fed with basal
diet for 1 month and then with oxidized cholesterol diet
for 1 month (Table 2). During the experimental period,
water and food were always available. After feeding, all
rats were weighed. Blood samples taken from the tail
veins of the rats at 0, 2, 4, 6 and 8 weeks intervals were
analyzed. The plasma of blood samples were collected by
centrifugation (2000 g for 15 min) from blood and examined for aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP) activites. On
the 8 th week, livers and kidneys of the rats were quickly excised and weighed. Both relative ratios of liver or
kidney weight to body weight were obtained. The liver
was stored at -40°C for glutathione (GSH) and TBARS
determinations.

Table 1. Composition of the experimental diets for animal diet of taurine and oxidized cholesterol
Diets
Ingredient

Basel diet (%)

Taurine diet (%)

Oxidized cholesterol
diet (%)

Tau+oxidized
cholesterol diet (%)

Casein

20

20

20

20

Methionine

0.3

0.3

0.3

0.3

Cellulose

5

5

5

5

Corn oil

2

2

2

2

Cholesterol

3

3

0

0

Oxidized cholesterol

0

0

3

3

Choline

0.2

0.2

0.2

0.2

Mineral mix(a)

3.5

3.5

3.5

3.5

Vitamin mix(b)

1

1

1

1

Taurine

0

5

0

5

Corn starch

65

60

65

60

(a) Minerals per 100 g diet: NaCl 7.4 g, K 2C6H5O7 H2O 22g, K 2SO4 5.2 g, CaHPO4 50 g, MgO 2.4 g, FeC6H5O7 5H2O 0.6 g, MnCO3 0.35 g,
CuCO3 30 mg, CrK(SO4)2 12H2O 55mg, CoCl2 6H2O 10 mg, KI 1 mg, ZnCO3 160 mg.
(b) Vitamin per 100 g diet: thiamine 100 mg, riboflavin 150 mg, pyridoxine HCl 100mg, nicotinamide 1000 mg, D-panthenate 500 mg, folic
acid 50 mg, vitamine B12 0.1 mg, vitamin A 2.5× 105 IU, vitamin E 100 mg, calciferol 2 × 104 IU, vitamin C 3.7 × 103 mg.
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Table 2. The experimental diets in each group for 2 months
Months

Group
A

B

C

D

E

F

G

H

1

basal diet

taurine diet

oxidized
cholesterol diet

taurine+oxidized
cholesterol diet

oxidized
cholesterol diet

oxidized
cholesterol diet

taurine diet

basal diet

2

basal diet

taurine diet

oxidized
cholesterol diet

taurine+oxidized
cholesterol diet

taurine diet

basal diet

oxidized
cholesterol diet

oxidized
cholesterol diet

IV. Assays of Enzymatic Activities
The plasma was determined for AST, ALT and ALP
activities by using enzymatic kit with Selectra Analyser
(Merck Co. Ltd, Germany).
V. Thiobarbituric Acid-Reactive Substances (TBARS)
Production
Lipid peroxidation activities in the liver were
assayed by measurement of malondialdehyde (MDA), an
end-product of peroxidized fatty acids, and thiobarbituric acid (TBA) reaction product. The sample of 20%
liver homogenate was mixed with 1.0 mL 0.4% TBA in
0.2 N HCl and 0.15 mL 0.2% BHT in 95% ethanol. The
samples were incubated in a 90°C water-bath for 45 min.
After incubation, the TBAMDA adduct was extracted
with isobutanol. The isobutanol extract was mixed with
methanol (2:1) prior to injection into the system of high
performance liquid chromatography (HPLC) on a Hitachi liquid chromatograph of Model L-6200 pump (Tokyo,
Japan). The supernatant was examined by HPLC monitored by excitation at 515 nm and an emission at 550
nm on a Hitachi fluorescence detector of Model L-4000
(Tokyo, Japan)(25).

range tests (27). A P value < 0.05 was considered statistically significant.

RESULTS
The effects of taurine and oxidized cholesterol on
the growth of rats are shown in Figure 1. After 8 wk of
feeding, the weight of rats fed without oxidized cholesterol diet (group A and group B) was significantly gained
among all tested groups (P < 0.05). This indicated that
oxidized cholesterol retarded the growth of rats. The
weight of rats fed with oxidized cholesterol diet for
2 months (group C), was less than that of rats fed with
taurine+oxidized cholesterol diet for 2 months (group
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GSH reacts non-enzymatically with 5, 5’-dithiobis (2-nitrobenzoic acid) (DTNB) to yield glutathione
disulfide (GSSG) and 2-nitro-5-thiobenzoic acid (TNB).
GSSG is then reduced enzymatically by NADPH and
glutathione reductase (GR) to regenerate GSH. Concentrations of DTNB, NADPH and GR were chosen such that
the rate of the overall reaction is linearly proportional to
the concentration of total GSH. The rate of formation of
TNB was followed spectrophotometrically, and the assay
was calibrated using standards. If the sample was reacted
with 2-vinylpyridine, GSH is derivatized, and only GSSG
can be detected during subsequent assay(26).
VII. Statistical Analysis
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Statistical analysis for differences among rats in the
experimental groups was performed by the 2-way analysis of variance procedure and Duncan’s new multiple

Figure 1. Effect of oxidized cholesterol and taurine on the growth
of rats. a-e: values in the same week with different superscript are
significantly different (P < 0.05).
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D) (P < 0.05). This meant that taurine reduced the toxicity of oxidized cholesterol on the weight of rats. Rats fed
with oxidized cholesterol diet for 1 month and then with
taurine diet for 1 month (group E), were heavier than
rats fed with oxidized cholesterol diet for 1 month and
then with basal diet for 1 month (group F). This showed
that taurine exhibited a recovering effect on the toxicity of oxidized cholesterol. However, the weight of rats
fed with taurine diet for 1 month and then with oxidized
cholesterol diet for 1 month (group G) was not significantly different from that of rats fed with basal diet for
1 month and then with basal diet for 1 month (group H)
(P < 0.05), meaning that taurine had no preventing effect
from the toxicity of oxidized cholesterol on the weight
of rats. The effects of taurine and oxidized cholesterol
on the relative ratios of liver and kidney weight to body
weight in rats are shown in Figure 2. After 8 wk of feeding, the ratios of liver and kidney weight to body weight
of rats fed with oxidized cholesterol diet for 2 months
(group C) were more significantly increased than those of
rats fed with control diet (group A), taurine diet (group
B) and taurine+oxidized cholesterol diet (group E) (P
< 0.05). On the other hand, the ratio of liver or kidney

Liver weight/ body weight (%)

4

Liver

c

c
b

b

3
a a

a a

weight to body weight in rats fed with taurine+oxidized
cholesterol diet (group E) was not significantly different from those of rats, fed with control diet (group A)
and taurine diet (group B) (P < 0.05). This meant that
taurine might reduce the toxicity of oxidized cholesterol
in the rats based on the relative ratio of liver or kidney to
body weight of rats. The ratios of liver or kidney weight
to body weight in rats fed oxidized cholesterol diet for 1
month and then with taurine diet for 1 month (group E)
was significantly less than those of rats fed with oxidized
cholesterol diet for 1 month and then with basal diet for 1
month (group F) (P < 0.05), indicating that taurine exhibited a recovering effect on the toxicity of oxidized cholesterol. Meanwhile, the ratios of liver or kidney weight to
body weight in rats fed with taurine diet for 1 month and
then with oxidized cholesterol diet for 1 month (group
G) was not significantly different from those of rats fed
with basal diet for 1 month and then with basal diet for
1 month (group H) (P < 0.05). This meant that taurine
had no preventing effect from the toxicity of oxidized
cholesterol based on the ratio of liver or kidney weight to
body weight in rats. The effects of oxidized cholesterol
and taurine on the activities of AST, ALT and ALP in the
plasma were, respectively, shown in Figures 3-5.
It was found that the activities of ALT and ALP
in the plasma of rats fed oxidized cholesterol diet for 2
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Figure 2. Effect of oxidized cholesterol and taurine on the ratios of
liver and kidney weight to body weight in rats. a-d: values in the same
week with different superscript are significantly different (P < 0.05).
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Figure 3. Effect of oxidized cholesterol and taurine on the activity of
aspartate transamine (AST) in the plasma of rats. a-c: values in the
same week with different superscript are significantly different (P <
0.05).
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months (group C) were the most significantly elevated among all tested groups (Figure 4 and Figure 5) (P
< 0.05). The activities of AST, ALT and ALP in those
rats fed taurine+oxidized cholesterol diet for 2 months
(group D) were significantly less than those of rats fed
with oxidized cholesterol diet for 2 months (group C) (P
< 0.05), which indicated that taurine showed a reducing
effect on the toxicity of oxidized cholesterol based on the
activities of AST, ALT and ALP in the plasma of rats.
The activities of AST, ALT and ALP in the plasma of rats
fed oxidized cholesterol diet for 1 month and then with
taurine diet for 1 month (group E) were significantly less
than those of rats, fed with oxidized cholesterol diet for
1 month and then with basal diet for 1 month (group F)
(P < 0.05). This indicated that taurine exerted a recovering effect on the toxicity of oxidized cholesterol.
Furthermore, the activities of ALT, AST and ALP in the
plasma of rats fed the taurine diet for 1 month and then
with oxidized cholesterol diet for 2 wk (group G) were
significantly less than those of rats fed with basal diet
for 1 month and then with oxidized cholesterol diet for 2
wk (group H) (P < 0.05). However, ALT and ALP activities in the plasma of rats fed taurine diet for 1 month and
then with oxidized cholesterol diet for 1 month (group
G) were also less than those of rats fed the taurine diet
for 1 month and then with oxidized cholesterol diet for
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1 month (group H) (P < 0.05), indicating that taurine
exhibited a short-term preventing effect from the toxicity of oxidized cholesterol on the activities of AST, ALT
and ALP in the plasma of rats. The effects of taurine
and oxidized cholesterol based on the concentrations
of TBARS and GSH in the liver of rats are shown in
Figure 6. After 8 wk of feeding, the level of TBARS in
the liver of rats, fed with oxidized cholesterol diet for 2
months (group C) and fed with oxidized cholesterol diet
for 1 month and then with basal diet for 1 month (group
H) was higher than that of other groups (P < 0.05). This
indicated that taurine revealed a reducing effect on the
toxicity of oxidized cholesterol based on the concentration of TBARS. The level of TBARS in the liver of rats
fed the oxidized cholesterol diet for 1 month and then the
taurine diet for 1 month (group E) was less than that of
rats fed with oxidized cholesterol diet for 1 month and
then with basal diet for 1 month (group F), indicating
that taurine exerted a recovering effect on the toxicity of
oxidized cholesterol. No difference was found between
levels of TBARS in the liver of rats in group G (fed with
taurine diet for 1 month and then with oxidized cholesterol diet for 1 month) and group H (fed with basal diet
for 1 month and then oxidized cholesterol for 1 month)
(P < 0.05), showing that taurine did not have a preventing effect from the toxicity of oxidized cholesterol based
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Figure 4. Effect of oxidized cholesterol and taurine on the activity
of alanine transamine (ALT) in the plasma of rats. a-d: values in the
same week with different superscript are significantly different (P <
0.05).
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Figure 5. Effect of oxidized cholesterol and taurine on the activity of
alkaline phosphatase (ALP) in the plasma of rats. a-d: values in the
same week with different superscript are significantly different (P <
0.05).
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reducing the toxic effect of oxidized cholesterol in rats.
Taurine could increase the body weight of rats and GSH
level of liver in rats, and decrease the enlargement of
liver and kidney, the enzymatic activities of AST, ALT
and ALP in the plasma, and TBARS level in the liver of
rats. Taurine showed a good function in reducing toxicity
of oxidized cholesterol in rats when the rats fed diet with
the supplement of oxidized cholesterol and taurine at the
same time, or fed diet with the supplement of oxidized
cholesterol and then taurine. Taurine also showed a
short-term preventing effect in reducing the toxicity of
oxidized cholesterol.
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Fig ure 6 . Ef fect of ox id i zed cholesterol a nd t au r i ne on t he
concentration of glutathione (GSH) and level of thiobarbituric acid
reactive substances (TBARS) in the liver of rats. a-g: values in the
same week with different superscript are significantly different (P <
0.05).

on the TBARS level. The concentration of GSH in the
liver of rats fed with taurine diet for 2 months (group
B) was the highest among all tested groups (Figure 6),
meaning that taurine played a role in increasing the GSH
level of liver in rats. The concentration of GSH in the
liver of rats fed the oxidized cholesterol diet for 1 month
and then basal diet for 1 month (group E) was less than
that of rats fed the oxidized cholesterol diet for 1 month
and then the taurine diet for 1 month (group F) (P < 0.05)
indicated that taurine exhibited a recovering effect on the
toxicity of oxidized cholesterol. The concentration of
GSH in the liver of rats fed taurine diet for 1 month and
then oxidized cholesterol diet for 1 month (group G) was
higher than that of rats fed with basal diet for 1 month
and then the oxidized cholesterol diet for 1 month (group
H) (P < 0.05), showing that taurine revealed a preventing effect from the toxicity of oxidized cholesterol. But
this functional effect was low because the level of GSH
in the liver of rats was increased slightly. Judging from
the above data, taurine might play an important role in

In this study, the activities of AST, ALT and ALP in
the plasma of rats were shown to be significantly affected
by oxidized cholesterol. In the clinical plasma examination, AST, ALT and ALP activities in plasma serve as
biomarkers for liver functions(28), The activities of AST
for 8 wk were most significantly elevated meaning that
oxidized cholesterol might injure liver function. Taurine
significantly reduced the enzymatic activities of AST,
ALT and ALP in the plasma of rats, indicating that the
liver injury by oxidized cholesterol could be ameliorated
by taurine. Wright et al.(29) pointed out that the function
of taurine for preserving liver cells was presented by the
high content of taurine in cell membrane. In the experimental period, the food consumption of rats was found
to significantly decrease in those groups of rats fed with
oxidized cholesterol diet. However, it is accompanied by
adverse side effects such as nephrotoxicity and hepatotoxicity(3). The palatability of the diet might also be affected.
Therefore, the oxidized cholesterol diet may induce liver
injury and reduce diet palatability in rats. TBARS is an
end-product of lipid peroxidation. The level of TBARS
in the liver was increased when the rats were fed oxidized
cholesterol. This means that the liver injury caused by
feeding with oxidized cholesterol was due to the induction of the lipid peroxidation of liver cells. The level
of TBARS in the liver of rats was significantly reduced
when the rats were fed with the supplement of taurine.
This result is the same as that reported previously(30-34).
Therefore, it is reasonable to assume that taurine may act
as a good scavenger in reducing the production of lipid
peroxidation induced by drugs(30), heavy metal(31), vitamin A (32) and oxidized cholesterol. Meanwhile, the function of GSH to protect biological organisms from xenobiotic injuries is well known(25, 35-37).
Lipid peroxidation is a chemical mechanism capable
of disrupting the structure and function of the biological
membranes that occurs as a result of free radical attacking
on lipids. When reactive oxygen species (ROS) begin to
accumulate, hepatic cells exhibit a defensive mechanism
by various antioxidant enzymes. The main detoxifying
systems for peroxides are catalase and GSH(38). Catalase
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is an antioxidant enzyme, which destroys H 2O2 that can
form a highly reactive hydroxyl radical in presence of
iron as a catalyst (39). By participating in the glutathione
redox cycle, GSH together with GSH-Px convert H 2O2
and lipid peroxides to non-toxic products. Reduced activity of one or more antioxidant systems due to the direct
toxic effect of oxidized cholesterol leads to increased lipid
peroxidation, oxidative stress, and hepatotoxicity. In the
current study, oxidized cholesterol depleted GSH reservoir and reduced catalase and GSH-Px activities. These
results are in harmony with other investigations(40). For
example, oxidized cholesterol induced hepatotoxicity was
exacerbated by GSH depletion. In the current study, the
depletion of GSH reservoir can account for the inhibition
of GSH-Px activity. In addition, high levels of peroxides
may explain catalase activity inhibition(41).
Taurine supplementation in our study significantly
mitigated oxidized cholesterol induced oxidative stress
and hepatotoxicity. This was clearly manifested by the
improvement in all the biochemical variables determining oxidized cholesterol hepatotoxicity (Figures. 3-6). In
addition, taurine inhibited lipid peroxidation, diminished
the decrease in catalase and GSH-Px activities, and abrogated GSH depletion induced by oxidized cholesterol.
Consistent with our finding, taurine has been
demonstrated to protect against hepatotoxicity induced
by several free radicals generating insults including lipopolysaccharide (42), acetaminophen(43), thioacetamide (44),
and ischemia/reperfusion(45). Moreover, the antioxidant
effect of taurine was shown in other organs including the
lung(46), kidney(47) and heart (48). In addition, other antioxidants have been shown to reduce oxidized cholesterol
induced hepatotoxicity.
Taurine has been demonstrated to function as a direct
antioxidant that scavenges or quenches oxygen free radicals, thus inhibiting lipid peroxidation, and as an indirect antioxidant that prevents the increase in membrane
permeability resulting from oxidant injury in many tissues
including liver (45). Taurine might stimulate s-nitrosylation of GSH producing s-nitrosoglutathione, which is
approximately 100 times more potent than the classical
GSH. In addition, s-nitrosylation of cysteine residues by
nitrosoglutathione can inactivate caspase-3, thus preventing hepatic cell apoptosis(49). Moreover, taurine might
lessen oxidized cholesterol induced oxidative injury either
by forming chloramines, known to be more stable and less
reactive molecules, with hypochlorous (HOCl) and HOClmetalloproteins, or by binding free metal ions such as
Fe2+ to its sulfonic acid group (50,51).
As an indirect antioxidant, taurine has been proposed
as a membrane stabilizer that can maintain membrane
organization, prevent ion leakage and water influx, and
subsequently, avoid cell swelling(45,48). The stabilizing effect of taurine on cellular membrane has been
suggested to be associated with the interaction between
taurine and polyunsaturated fatty acids in the membrane,
which results in increasing in the affinity of taurine for

its carrier transport and the interaction between taurine
and the sites related to anion transport and water influx.
This property of taurine may also partly account for its
protection against oxidized cholesterol induced hepatocyte necrosis.
On the other hand, taurine can also function as a
regulator of intracellular calcium homeostasis (13) that can
be disturbed due to oxidized cholesterol toxicity. Taurine
has been shown to protect against endothelial cell death
by modulating intracellular calcium fluxes (52). Finally,
taurine may ameliorate oxidized cholesterol induced
hepatic injury by enhancing the activities of endogenous
antioxidants. Support for this concept comes from our
results, which show that taurine promoted a remarkable
significant increase in hepatic GSH level and GSH-Px
and catalase activities. This could be attributed to the
role of taurine in maintaining a normal IGF-I level(53)
and its antioxidant action against lipid peroxidation, thus
conserving the internal antioxidants system. The stimulatory effect of taurine on endogenous antioxidants was
reported by others (47,54). Together, the results of the present study demonstrate that administration of taurine has
a therapeutic role in preventing cyclosporine-induced
hepatotoxicity, possibly through its unique cytoprotective
properties such as antioxidant activity.
In conclusion, we suggest that: (a) the imbalance
between production of oxygen free radicals and the
endogenous antioxidant defense system, as a result of
the effect of oxidized cholesterol, is the main mechanism
responsible for peroxide accumulation and hepatotoxicity; and (b) taurine reduces the oxidative stress through
the inhibition of lipid peroxidation (a widely known
mechanism).
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